🇺🇸 Fluad_MF59-adjuvanted trivalent influenza subunit vaccine in United States

Fluad_MF59-adjuvanted trivalent influenza subunit vaccine (Fluad_MF59-adjuvanted trivalent influenza subunit vaccine) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Fluad_MF59-adjuvanted trivalent influenza subunit vaccine in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Fluad_MF59-adjuvanted trivalent influenza subunit vaccine approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Fluad_MF59-adjuvanted trivalent influenza subunit vaccine in United States?

Novartis Vaccines is the originator. The local marketing authorisation holder may differ — check the official source linked above.